The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 772K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

10 articles for M Getlik


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
16
Structure-Based Optimization of a Small Molecule Antagonist of the Interaction Between WD Repeat-Containing Protein 5 (WDR5) and Mixed-Lineage Leukemia 1 (MLL1).EBI
Ontario Institute For Cancer Research
38
Targeting Drug Resistance in EGFR with Covalent Inhibitors: A Structure-Based Design Approach.EBI
Tu Dortmund University
17
Targeting gain of function and resistance mutations in Abl and KIT by hybrid compound design.EBI
Technical University of Dortmund
40
Synthesis, Optimization, and Evaluation of Novel Small Molecules as Antagonists of WDR5-MLL Interaction.EBI
Entremed
14
Structure-based design, synthesis and biological evaluation of N-pyrazole, N'-thiazole urea inhibitors of MAP kinase p38a.EBI
Chemical Genomics Centre of The Max Planck Society
28
Displacement assay for the detection of stabilizers of inactive kinase conformations.EBI
Chemical Genomics Centre of The Max Planck Society
1
Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia.EBI
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
59
2-pyridyloxy-4-ether orexin receptor antagonistsBDB
Merck Sharp & Dohme
7
Structural Insight into the Stereoselective Inhibition of MMP-8 by Enantiomeric Sulfonamide Phosphonates.BDB
Istituto Di Cristallografia